Webinar | Sodium Reduction Solutions That Pass The Cost, Safety, And Consumer Test: Register Now

Lingyi Biology

Lingyi Bio is a rare disease animal model functional verification platform and gene therapy developer.
2021
11 – 50
Shanghai, Shanghai, China

Investment Funding

Last Funding Stage

Early Stage Venture

Total Funding Amount

$30.3M

Last Funding Date

25-11-2024

Startup Stage

Series A

Lead Investors

Beijing Huafang Investment, HSG, Jolly Pharmaceutical, Matrix Partners China, Yifeng Capital

Something missing or incorrect on this page? Help us enrich this information